Bedi; Atul

Patent Applications and Registrations

Patent applications and USPTO patent grants for Bedi; Atul.The latest application filed is for "compositions and methods for targeted immunomodulatory antibodies and fusion proteins".

Company Profile

4.6.11

Bedi; Atul - Timonium MD
Bedi; Atul - Baltimore MD

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Compositions And Methods For Targeted Immunomodulatory Antibodies And Fusion Proteins App 20220204628 - Bedi; Atul ; et al.	2022-06-30
Compositions and methods for targeted immunomodulatory antibodies and fusion proteins Grant 11,274,156 - Bedi , et al. March 15, 2	2022-03-15
Molecules, Compositions And Methods For Treatment Of Cancer App 20210107969 - Bedi; Atul ; et al.	2021-04-15
Multifunctional Antibody-ligand Traps To Modulate Immune Tolerance App 20200140547 - Bedi; Atul ; et al.	2020-05-07
Compositions And Methods For Targeted Immunomodulatory Antibodies And Fusion Proteins App 20200115455 - Bedi; Atul ; et al.	2020-04-16
Compositions and methods for targeted immunomodulatory antibodies and fusion proteins Grant 10,442,860 - Bedi , et al. Oc	2019-10-15
Compositions and methods for targeted immunomodulatory antibodies and fusion proteins Grant 9,850,306 - Bedi , et al. December 26, 2	2017-12-26
Compositions And Methods For Targeted Immunomodulatory Antibodies And Fusion Proteins App 20170158770 - Bedi; Atul ; et al.	2017-06-08
Compositions And Methods For Targeted Immunomodulatory Antibodies And Fusion Proteins App 20160340430 - Bedi; Atul ; et al.	2016-11-24
Compositions and methods for targeted immunomodulatory antibodies and fusion proteins Grant 9,441,044 - Bedi , et al. September 13, 2	2016-09-13
Compositions And Methods For Targeted Immunomodulatory Antibodies And Fusion Proteins App 20150183881 - Bedi; Atul ; et al.	2015-07-02
Compositions and methods for targeted immunomodulatory antibodies and fusion proteins Grant 8,993,524 - Bedi , et al. March 31, 2	2015-03-31
Compositions and Methods for Targeted Immunomodulatory Antibodies and Fusion Proteins App 20130039911 - Bedi; Atul ; et al.	2013-02-14
Polypeptide-Nucleic Acid Conjugate for Immunoprophylaxis or Immunotherapy for Neoplastic or Infectious Disorders App 20090123467 - Bedi; Atul ; et al.	2009-05-14
Polypeptide-nucleic acid conjugate for immunoprophylaxis or immunotherapy for neoplastic or infectious disorders App 20070212337 - Bedi; Atul ; et al.	2007-09-13

Company Registrations

NCAGE Code	46SL1	BEDI ATUL
CAGE Code	46SL1	BEDI, ATUL

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.